Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from LLY

Do Wall Street Analysts Like Eli Lilly Stock?

Eli Lilly stock has outperformed the broader market over the past year, and Wall Street analysts remain optimistic about the stock’s prospect.

Eli Lilly (LLY) vs. Novo Nordisk (NVO): Which Pharma Stock Is Driving Long-Term 2024 Profits?

Eli Lilly (LLY) vs. Novo Nordisk (NVO): Which Pharma Stock Is Driving Long-Term 2024 Profits?

The pharmaceutical market is poised for rapid expansion due to rising global medical needs and increasing integration of technologies in drug discovery and development. Amid this, let’s analyze Eli Lilly (LLY) and Novo Nordisk (NVO) to determine which pharma stock will drive long-term profits in 2024. Read more to find…

Dow Jones Futures Fall As Target Tumbles; Nvidia Looms Over Stock Market

Dow Jones Futures Fall As Target Tumbles; Nvidia Looms Over Stock Market

The Nasdaq hit a new high Tuesday but Target tumbled early Wednesday. Will Nvidia earnings tonight meet lofty hopes?

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

1 'Strong Buy' Dividend Stock to Buy and Hold

Discover why Eli Lilly is considered a 'strong buy' as it capitalizes on the growing demand for diabetes and obesity treatments, backed by its robust financial performance and promising future prospects.

Eli Lilly (LLY) or Pfizer (PFE): Which Stock Can Surge From Earnings?

Amid increasing healthcare spending, breakthroughs in genomics and personalized medicine, and the adoption of new technologies, the pharma industry is booming. So, let’s analyze Eli Lilly (LLY) and Pfizer (PFE) to determine which pharma stock will surge from their first-quarter earnings. Read on to find out.

Dow Jones Futures Fall As Fed Looms; Amazon Rises As AMD, Super Micro Plunge

The market rally stumbled ahead of the Fed meeting. Amazon rose on earnings while AI plays Super Micro and AMD plunged.

Investors Business Daily

Dow Jones Futures: Market Rally Holds Support, Meta Near Buy Point; Tesla Skid Continues

Stocks retreated Tuesday as Treasury yields hit 2024 highs. Tesla tumbled, but Meta and Eli Lilly are hanging tough.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Futures: Small Caps Jump As Nvidia, Growth Leaders Skid

Dow Jones Futures: Small Caps Jump As Nvidia, Growth Leaders Skid

Small caps lead the stock market's broad advance Wednesday, but Nvidia and other growth leaders retreated.

Investors Business Daily

Dow Jones Futures Fall: Fed, AI Boom Keep Driving Market; 3 Stocks Near Buy Points

Dow Jones Futures Fall: Fed, AI Boom Keep Driving Market; 3 Stocks Near Buy Points

The dovish Fed and the Nvidia-led AI boom continue to be the big stock market catalysts. Uber and Eli Llly are setting up in messy bases.

Investors Business Daily

Dow Jones Futures Fall: Taiwan Semi, 7 Leaders Offer New Chance; Super Micro Soars On S&P 500 News

Dow Jones Futures Fall: Taiwan Semi, 7 Leaders Offer New Chance; Super Micro Soars On S&P 500 News

The Nasdaq hit a record high, but is again extended. Taiwan Semi was among leaders offering new entries. Super Micro soared on S&P 500 news.

Investors Business Daily

Navigate to Success With These 4 Pharma Stocks to Buy

Navigate to Success With These 4 Pharma Stocks to Buy

The pharmaceutical industry is expanding due to increased demand for healthcare products and technological advancements. Therefore, fundamentally strong pharma stocks Kamada (KMDA), Hypera (HYPMY), Eli Lilly (LLY) and Sanofi (SNY) might be ideal additions to your portfolio. Read on.

2 Obesity Treatment Stocks Morgan Stanley Likes More than Novo Nordisk

2 Obesity Treatment Stocks Morgan Stanley Likes More than Novo Nordisk

While Novo Nordisk's Wegovy currently dominates the obesity treatment market, Morgan Stanley sees more upside potential for LLY and AZN stocks going forward.

3 Mega-Cap Stocks That Could Replace Tesla in the 'Magnificent Seven'

3 Mega-Cap Stocks That Could Replace Tesla in the 'Magnificent Seven'

As Tesla stock continues to underperform - now down more than 22% year-to-date - here are 3 mega-cap companies worthy of replacing the beleaguered EV giant in the elite group of mega-cap stocks known as the Magnificent Seven.

Will Weight-Loss, Diabetes Drugs Drive LLY Stock Into $1 Trillion Club?

Will Weight-Loss, Diabetes Drugs Drive LLY Stock Into $1 Trillion Club?

Eli Lilly's weight-loss and diabetes drugs Zepbound and Mounjaro should drive the biopharma stock much higher, said a Morgan Stanley analyst.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

It's Not Too Late to Buy Eli Lilly Stock. Here's Why.

J.P. Morgan thinks sales of weight-loss drugs could exceed $100 billion by 2030. That's good news for Eli Lilly, which is now the largest pharma company by market capitalization and the 9th-biggest S&P 500 stock. Here's why LLY stock looks poised to put on even more weight in the months…

Investors Business Daily

Why Lilly's New Weight-Loss Study Absolutely Crushed 89bio, Akero, Madrigal

Eli Lilly stock pulled back from bullish gains Tuesday despite strong weight-loss drug sales and a promising test in liver disease treatment.

Eli Lilly & Co. (LLY) Pre-Earnings Moves: Buy or Watch?

Eli Lilly (LLY) saw steady growth in its last reported quarter, driven by sales from its popular diabetes drug Mounjaro. The stock has had an impressive run over the past year. However, will the momentum be sustained following its upcoming earnings release scheduled for tomorrow? Read on.

Top 3 Smart Pharma Picks for Good Investments

As global medical needs and technology evolve, the pharmaceutical industry is expected to thrive. Therefore, fundamentally strong pharma stocks Eli Lilly (LLY), AstraZeneca (AZN) and GSK (GSK) might be ideal additions to your portfolio. Read on.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Short Moves In Eli Lilly Stock Good For Swing Trading

Eli Lilly stock was great to own during the pullback at the beginning of the year. It might be again.

What’s the Best 2024 Pharma Stock Buy Among These 3 Stocks?

The pharma industry's potential for sustained growth is reinforced by an aging population, escalating healthcare demands, and the increase in chronic diseases. Therefore, let’s assess the fundamentals of pharma stocks Eli Lilly (LLY), Johnson & Johnson (JNJ), and Abbvie (ABBV) to determine the most promising choice for the current year….

Investors Business Daily

These 9 Stocks Are Running To Start 2024

The S&P 500 rebounded last week near record highs, but is up just 0.2% so far in 2024. These are the index's top performers so far.

Iron Condor Alert: LLY Stock Could Net 40% In 4 Weeks

Eli Lilly (LLY) is showing elevated implied volatility with an IV Percentile of 98%, and that could mean it’s a good time for an iron condor trade.

Top 4 Pharma Picks for January 2024 Growth

The pharmaceutical industry’s future is increasingly promising, spurred by a rise in healthcare expenditure amid escalating chronic and rare disease cases and a burgeoning aged population. The industry's bright outlook is also strengthened by consistent forays into research and development. Against this backdrop, quality pharma stocks Pacira BioSciences (PCRX), Eli…

Investors Business Daily

Alphabet's Isomorphic Labs In Drug Discovery Deals With Eli Lilly, Novartis

Alphabet unit Isomorphic Labs, which uses AI to help discover new drugs, entered collaboration deals with Eli Lilly and Novartis.

Investors Business Daily

Dow Jones Futures Fall As Boeing Plunges On 737 Max Woes; Can Market Rally Hold Key Levels?

Dow Jones futures fell as the FAA grounded many Boeing 737 Max-9 jets after a midair incident on Friday. Can the market rally hold key levels?

People

Dipanjan BanchurSince

Mangeet Kaur BounsMangeet

Christopher Waller

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

302,312 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play